[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Covid-19 Protein Market Growth 2024-2030

May 2024 | 107 pages | ID: GD0D082276EFEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The human coronavirus nucleoprotein (N protein) is a crucial component of the coronavirus virion (virus particle). Coronaviruses are a family of viruses that can cause respiratory illnesses in humans and animals.

The global Human Covid-19 Protein market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Human Covid-19 Protein Industry Forecast” looks at past sales and reviews total world Human Covid-19 Protein sales in 2023, providing a comprehensive analysis by region and market sector of projected Human Covid-19 Protein sales for 2024 through 2030. With Human Covid-19 Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Covid-19 Protein industry.

This Insight Report provides a comprehensive analysis of the global Human Covid-19 Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Covid-19 Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Covid-19 Protein market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Covid-19 Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Covid-19 Protein.

United States market for Human Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human Covid-19 Protein players cover Abcam, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Covid-19 Protein market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 90%?Purity?95%
  • Purity?95%
  • Other
Segmentation by Application:
  • Vaccine Development
  • Antiviral Drugs
  • Research
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Abcam
  • The Native Antigen Company
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Agrisera
  • Merck KGaA (Sigma-Aldrich)
  • Seebio
  • Elabscience
  • Novus Biologicals
  • Sinobiological
  • Eagle Biosciences
  • BiosPacific
Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Covid-19 Protein market?

What factors are driving Human Covid-19 Protein market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Covid-19 Protein market opportunities vary by end market size?

How does Human Covid-19 Protein break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Covid-19 Protein Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Human Covid-19 Protein by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Human Covid-19 Protein by Country/Region, 2019, 2023 & 2030
2.2 Human Covid-19 Protein Segment by Type
  2.2.1 90%?Purity?95%
  2.2.2 Purity?95%
  2.2.3 Other
2.3 Human Covid-19 Protein Sales by Type
  2.3.1 Global Human Covid-19 Protein Sales Market Share by Type (2019-2024)
  2.3.2 Global Human Covid-19 Protein Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Human Covid-19 Protein Sale Price by Type (2019-2024)
2.4 Human Covid-19 Protein Segment by Application
  2.4.1 Vaccine Development
  2.4.2 Antiviral Drugs
  2.4.3 Research
  2.4.4 Other
2.5 Human Covid-19 Protein Sales by Application
  2.5.1 Global Human Covid-19 Protein Sale Market Share by Application (2019-2024)
  2.5.2 Global Human Covid-19 Protein Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Human Covid-19 Protein Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Human Covid-19 Protein Breakdown Data by Company
  3.1.1 Global Human Covid-19 Protein Annual Sales by Company (2019-2024)
  3.1.2 Global Human Covid-19 Protein Sales Market Share by Company (2019-2024)
3.2 Global Human Covid-19 Protein Annual Revenue by Company (2019-2024)
  3.2.1 Global Human Covid-19 Protein Revenue by Company (2019-2024)
  3.2.2 Global Human Covid-19 Protein Revenue Market Share by Company (2019-2024)
3.3 Global Human Covid-19 Protein Sale Price by Company
3.4 Key Manufacturers Human Covid-19 Protein Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Human Covid-19 Protein Product Location Distribution
  3.4.2 Players Human Covid-19 Protein Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HUMAN COVID-19 PROTEIN BY GEOGRAPHIC REGION

4.1 World Historic Human Covid-19 Protein Market Size by Geographic Region (2019-2024)
  4.1.1 Global Human Covid-19 Protein Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Human Covid-19 Protein Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Covid-19 Protein Market Size by Country/Region (2019-2024)
  4.2.1 Global Human Covid-19 Protein Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Human Covid-19 Protein Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Covid-19 Protein Sales Growth
4.4 APAC Human Covid-19 Protein Sales Growth
4.5 Europe Human Covid-19 Protein Sales Growth
4.6 Middle East & Africa Human Covid-19 Protein Sales Growth

5 AMERICAS

5.1 Americas Human Covid-19 Protein Sales by Country
  5.1.1 Americas Human Covid-19 Protein Sales by Country (2019-2024)
  5.1.2 Americas Human Covid-19 Protein Revenue by Country (2019-2024)
5.2 Americas Human Covid-19 Protein Sales by Type (2019-2024)
5.3 Americas Human Covid-19 Protein Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Covid-19 Protein Sales by Region
  6.1.1 APAC Human Covid-19 Protein Sales by Region (2019-2024)
  6.1.2 APAC Human Covid-19 Protein Revenue by Region (2019-2024)
6.2 APAC Human Covid-19 Protein Sales by Type (2019-2024)
6.3 APAC Human Covid-19 Protein Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Human Covid-19 Protein by Country
  7.1.1 Europe Human Covid-19 Protein Sales by Country (2019-2024)
  7.1.2 Europe Human Covid-19 Protein Revenue by Country (2019-2024)
7.2 Europe Human Covid-19 Protein Sales by Type (2019-2024)
7.3 Europe Human Covid-19 Protein Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Covid-19 Protein by Country
  8.1.1 Middle East & Africa Human Covid-19 Protein Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Human Covid-19 Protein Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Covid-19 Protein Sales by Type (2019-2024)
8.3 Middle East & Africa Human Covid-19 Protein Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Covid-19 Protein
10.3 Manufacturing Process Analysis of Human Covid-19 Protein
10.4 Industry Chain Structure of Human Covid-19 Protein

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Human Covid-19 Protein Distributors
11.3 Human Covid-19 Protein Customer

12 WORLD FORECAST REVIEW FOR HUMAN COVID-19 PROTEIN BY GEOGRAPHIC REGION

12.1 Global Human Covid-19 Protein Market Size Forecast by Region
  12.1.1 Global Human Covid-19 Protein Forecast by Region (2025-2030)
  12.1.2 Global Human Covid-19 Protein Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Human Covid-19 Protein Forecast by Type (2025-2030)
12.7 Global Human Covid-19 Protein Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Abcam
  13.1.1 Abcam Company Information
  13.1.2 Abcam Human Covid-19 Protein Product Portfolios and Specifications
  13.1.3 Abcam Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Abcam Main Business Overview
  13.1.5 Abcam Latest Developments
13.2 The Native Antigen Company
  13.2.1 The Native Antigen Company Company Information
  13.2.2 The Native Antigen Company Human Covid-19 Protein Product Portfolios and Specifications
  13.2.3 The Native Antigen Company Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 The Native Antigen Company Main Business Overview
  13.2.5 The Native Antigen Company Latest Developments
13.3 Bio-Rad Laboratories
  13.3.1 Bio-Rad Laboratories Company Information
  13.3.2 Bio-Rad Laboratories Human Covid-19 Protein Product Portfolios and Specifications
  13.3.3 Bio-Rad Laboratories Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Bio-Rad Laboratories Main Business Overview
  13.3.5 Bio-Rad Laboratories Latest Developments
13.4 Thermo Fisher Scientific
  13.4.1 Thermo Fisher Scientific Company Information
  13.4.2 Thermo Fisher Scientific Human Covid-19 Protein Product Portfolios and Specifications
  13.4.3 Thermo Fisher Scientific Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Thermo Fisher Scientific Main Business Overview
  13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Agrisera
  13.5.1 Agrisera Company Information
  13.5.2 Agrisera Human Covid-19 Protein Product Portfolios and Specifications
  13.5.3 Agrisera Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Agrisera Main Business Overview
  13.5.5 Agrisera Latest Developments
13.6 Merck KGaA (Sigma-Aldrich)
  13.6.1 Merck KGaA (Sigma-Aldrich) Company Information
  13.6.2 Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Product Portfolios and Specifications
  13.6.3 Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Merck KGaA (Sigma-Aldrich) Main Business Overview
  13.6.5 Merck KGaA (Sigma-Aldrich) Latest Developments
13.7 Seebio
  13.7.1 Seebio Company Information
  13.7.2 Seebio Human Covid-19 Protein Product Portfolios and Specifications
  13.7.3 Seebio Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Seebio Main Business Overview
  13.7.5 Seebio Latest Developments
13.8 Elabscience
  13.8.1 Elabscience Company Information
  13.8.2 Elabscience Human Covid-19 Protein Product Portfolios and Specifications
  13.8.3 Elabscience Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Elabscience Main Business Overview
  13.8.5 Elabscience Latest Developments
13.9 Novus Biologicals
  13.9.1 Novus Biologicals Company Information
  13.9.2 Novus Biologicals Human Covid-19 Protein Product Portfolios and Specifications
  13.9.3 Novus Biologicals Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Novus Biologicals Main Business Overview
  13.9.5 Novus Biologicals Latest Developments
13.10 Sinobiological
  13.10.1 Sinobiological Company Information
  13.10.2 Sinobiological Human Covid-19 Protein Product Portfolios and Specifications
  13.10.3 Sinobiological Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Sinobiological Main Business Overview
  13.10.5 Sinobiological Latest Developments
13.11 Eagle Biosciences
  13.11.1 Eagle Biosciences Company Information
  13.11.2 Eagle Biosciences Human Covid-19 Protein Product Portfolios and Specifications
  13.11.3 Eagle Biosciences Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Eagle Biosciences Main Business Overview
  13.11.5 Eagle Biosciences Latest Developments
13.12 BiosPacific
  13.12.1 BiosPacific Company Information
  13.12.2 BiosPacific Human Covid-19 Protein Product Portfolios and Specifications
  13.12.3 BiosPacific Human Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 BiosPacific Main Business Overview
  13.12.5 BiosPacific Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Human Covid-19 Protein Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Covid-19 Protein Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 90%?Purity?95%
Table 4. Major Players of Purity?95%
Table 5. Major Players of Other
Table 6. Global Human Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 7. Global Human Covid-19 Protein Sales Market Share by Type (2019-2024)
Table 8. Global Human Covid-19 Protein Revenue by Type (2019-2024) & ($ million)
Table 9. Global Human Covid-19 Protein Revenue Market Share by Type (2019-2024)
Table 10. Global Human Covid-19 Protein Sale Price by Type (2019-2024) & (US$/kg)
Table 11. Global Human Covid-19 Protein Sale by Application (2019-2024) & (kg)
Table 12. Global Human Covid-19 Protein Sale Market Share by Application (2019-2024)
Table 13. Global Human Covid-19 Protein Revenue by Application (2019-2024) & ($ million)
Table 14. Global Human Covid-19 Protein Revenue Market Share by Application (2019-2024)
Table 15. Global Human Covid-19 Protein Sale Price by Application (2019-2024) & (US$/kg)
Table 16. Global Human Covid-19 Protein Sales by Company (2019-2024) & (kg)
Table 17. Global Human Covid-19 Protein Sales Market Share by Company (2019-2024)
Table 18. Global Human Covid-19 Protein Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Human Covid-19 Protein Revenue Market Share by Company (2019-2024)
Table 20. Global Human Covid-19 Protein Sale Price by Company (2019-2024) & (US$/kg)
Table 21. Key Manufacturers Human Covid-19 Protein Producing Area Distribution and Sales Area
Table 22. Players Human Covid-19 Protein Products Offered
Table 23. Human Covid-19 Protein Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Human Covid-19 Protein Sales by Geographic Region (2019-2024) & (kg)
Table 27. Global Human Covid-19 Protein Sales Market Share Geographic Region (2019-2024)
Table 28. Global Human Covid-19 Protein Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Human Covid-19 Protein Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Human Covid-19 Protein Sales by Country/Region (2019-2024) & (kg)
Table 31. Global Human Covid-19 Protein Sales Market Share by Country/Region (2019-2024)
Table 32. Global Human Covid-19 Protein Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Human Covid-19 Protein Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Human Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 35. Americas Human Covid-19 Protein Sales Market Share by Country (2019-2024)
Table 36. Americas Human Covid-19 Protein Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Human Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 38. Americas Human Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 39. APAC Human Covid-19 Protein Sales by Region (2019-2024) & (kg)
Table 40. APAC Human Covid-19 Protein Sales Market Share by Region (2019-2024)
Table 41. APAC Human Covid-19 Protein Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Human Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 43. APAC Human Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 44. Europe Human Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 45. Europe Human Covid-19 Protein Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Human Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 47. Europe Human Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 48. Middle East & Africa Human Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 49. Middle East & Africa Human Covid-19 Protein Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Human Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 51. Middle East & Africa Human Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Human Covid-19 Protein
Table 53. Key Market Challenges & Risks of Human Covid-19 Protein
Table 54. Key Industry Trends of Human Covid-19 Protein
Table 55. Human Covid-19 Protein Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Human Covid-19 Protein Distributors List
Table 58. Human Covid-19 Protein Customer List
Table 59. Global Human Covid-19 Protein Sales Forecast by Region (2025-2030) & (kg)
Table 60. Global Human Covid-19 Protein Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Human Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 62. Americas Human Covid-19 Protein Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Human Covid-19 Protein Sales Forecast by Region (2025-2030) & (kg)
Table 64. APAC Human Covid-19 Protein Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Human Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 66. Europe Human Covid-19 Protein Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Human Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 68. Middle East & Africa Human Covid-19 Protein Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Human Covid-19 Protein Sales Forecast by Type (2025-2030) & (kg)
Table 70. Global Human Covid-19 Protein Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Human Covid-19 Protein Sales Forecast by Application (2025-2030) & (kg)
Table 72. Global Human Covid-19 Protein Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Abcam Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 74. Abcam Human Covid-19 Protein Product Portfolios and Specifications
Table 75. Abcam Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 76. Abcam Main Business
Table 77. Abcam Latest Developments
Table 78. The Native Antigen Company Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 79. The Native Antigen Company Human Covid-19 Protein Product Portfolios and Specifications
Table 80. The Native Antigen Company Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 81. The Native Antigen Company Main Business
Table 82. The Native Antigen Company Latest Developments
Table 83. Bio-Rad Laboratories Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Rad Laboratories Human Covid-19 Protein Product Portfolios and Specifications
Table 85. Bio-Rad Laboratories Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 86. Bio-Rad Laboratories Main Business
Table 87. Bio-Rad Laboratories Latest Developments
Table 88. Thermo Fisher Scientific Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher Scientific Human Covid-19 Protein Product Portfolios and Specifications
Table 90. Thermo Fisher Scientific Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Agrisera Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 94. Agrisera Human Covid-19 Protein Product Portfolios and Specifications
Table 95. Agrisera Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 96. Agrisera Main Business
Table 97. Agrisera Latest Developments
Table 98. Merck KGaA (Sigma-Aldrich) Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Product Portfolios and Specifications
Table 100. Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 101. Merck KGaA (Sigma-Aldrich) Main Business
Table 102. Merck KGaA (Sigma-Aldrich) Latest Developments
Table 103. Seebio Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 104. Seebio Human Covid-19 Protein Product Portfolios and Specifications
Table 105. Seebio Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 106. Seebio Main Business
Table 107. Seebio Latest Developments
Table 108. Elabscience Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 109. Elabscience Human Covid-19 Protein Product Portfolios and Specifications
Table 110. Elabscience Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 111. Elabscience Main Business
Table 112. Elabscience Latest Developments
Table 113. Novus Biologicals Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 114. Novus Biologicals Human Covid-19 Protein Product Portfolios and Specifications
Table 115. Novus Biologicals Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 116. Novus Biologicals Main Business
Table 117. Novus Biologicals Latest Developments
Table 118. Sinobiological Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinobiological Human Covid-19 Protein Product Portfolios and Specifications
Table 120. Sinobiological Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 121. Sinobiological Main Business
Table 122. Sinobiological Latest Developments
Table 123. Eagle Biosciences Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 124. Eagle Biosciences Human Covid-19 Protein Product Portfolios and Specifications
Table 125. Eagle Biosciences Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 126. Eagle Biosciences Main Business
Table 127. Eagle Biosciences Latest Developments
Table 128. BiosPacific Basic Information, Human Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 129. BiosPacific Human Covid-19 Protein Product Portfolios and Specifications
Table 130. BiosPacific Human Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 131. BiosPacific Main Business
Table 132. BiosPacific Latest Developments



LIST OF FIGURES

Figure 1. Picture of Human Covid-19 Protein
Figure 2. Human Covid-19 Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Covid-19 Protein Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Human Covid-19 Protein Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Human Covid-19 Protein Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Human Covid-19 Protein Sales Market Share by Country/Region (2023)
Figure 10. Human Covid-19 Protein Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 90%?Purity?95%
Figure 12. Product Picture of Purity?95%
Figure 13. Product Picture of Other
Figure 14. Global Human Covid-19 Protein Sales Market Share by Type in 2023
Figure 15. Global Human Covid-19 Protein Revenue Market Share by Type (2019-2024)
Figure 16. Human Covid-19 Protein Consumed in Vaccine Development
Figure 17. Global Human Covid-19 Protein Market: Vaccine Development (2019-2024) & (kg)
Figure 18. Human Covid-19 Protein Consumed in Antiviral Drugs
Figure 19. Global Human Covid-19 Protein Market: Antiviral Drugs (2019-2024) & (kg)
Figure 20. Human Covid-19 Protein Consumed in Research
Figure 21. Global Human Covid-19 Protein Market: Research (2019-2024) & (kg)
Figure 22. Human Covid-19 Protein Consumed in Other
Figure 23. Global Human Covid-19 Protein Market: Other (2019-2024) & (kg)
Figure 24. Global Human Covid-19 Protein Sale Market Share by Application (2023)
Figure 25. Global Human Covid-19 Protein Revenue Market Share by Application in 2023
Figure 26. Human Covid-19 Protein Sales by Company in 2023 (kg)
Figure 27. Global Human Covid-19 Protein Sales Market Share by Company in 2023
Figure 28. Human Covid-19 Protein Revenue by Company in 2023 ($ millions)
Figure 29. Global Human Covid-19 Protein Revenue Market Share by Company in 2023
Figure 30. Global Human Covid-19 Protein Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Human Covid-19 Protein Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Human Covid-19 Protein Sales 2019-2024 (kg)
Figure 33. Americas Human Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 34. APAC Human Covid-19 Protein Sales 2019-2024 (kg)
Figure 35. APAC Human Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 36. Europe Human Covid-19 Protein Sales 2019-2024 (kg)
Figure 37. Europe Human Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Human Covid-19 Protein Sales 2019-2024 (kg)
Figure 39. Middle East & Africa Human Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 40. Americas Human Covid-19 Protein Sales Market Share by Country in 2023
Figure 41. Americas Human Covid-19 Protein Revenue Market Share by Country (2019-2024)
Figure 42. Americas Human Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 43. Americas Human Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 44. United States Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Human Covid-19 Protein Sales Market Share by Region in 2023
Figure 49. APAC Human Covid-19 Protein Revenue Market Share by Region (2019-2024)
Figure 50. APAC Human Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 51. APAC Human Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 52. China Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 56. India Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Human Covid-19 Protein Sales Market Share by Country in 2023
Figure 60. Europe Human Covid-19 Protein Revenue Market Share by Country (2019-2024)
Figure 61. Europe Human Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 62. Europe Human Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 63. Germany Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 64. France Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Human Covid-19 Protein Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Human Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Human Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 71. Egypt Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Human Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Human Covid-19 Protein in 2023
Figure 77. Manufacturing Process Analysis of Human Covid-19 Protein
Figure 78. Industry Chain Structure of Human Covid-19 Protein
Figure 79. Channels of Distribution
Figure 80. Global Human Covid-19 Protein Sales Market Forecast by Region (2025-2030)
Figure 81. Global Human Covid-19 Protein Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Human Covid-19 Protein Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Human Covid-19 Protein Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Human Covid-19 Protein Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Human Covid-19 Protein Revenue Market Share Forecast by Application (2025-2030)


More Publications